Preparation method and application of mouse hypertension fundus lesion model caused by continuous angiotensin II perfusion

An angiotensin and hypertension technology, applied in the field of biomedicine, can solve the problems of difficult operation, long construction period, high technical difficulty, etc., and achieve the effect of increasing systolic blood pressure and increasing retinal inflammation

Pending Publication Date: 2022-06-28
THE SECOND HOSPITAL OF DALIAN MEDICAL UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these models still have limitations: ① animal models are concentrated in large animals such as rats and monkeys, and have high requirements for research sites and research funds; It takes at least 15 months to construct; ③The operation of animal models is relatively difficult, such as the suprarenal ao

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of mouse hypertension fundus lesion model caused by continuous angiotensin II perfusion
  • Preparation method and application of mouse hypertension fundus lesion model caused by continuous angiotensin II perfusion
  • Preparation method and application of mouse hypertension fundus lesion model caused by continuous angiotensin II perfusion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0042] The present application will be described in detail below with reference to the examples, but the present application is not limited to these examples.

[0043] A preparation method of a hypertensive retinopathy mouse animal model, comprising the following steps:

[0044] 1. Preparation of mice: Wild-type 10-week-old male mice with C57BL / 6J background were routinely raised, a total of 15 mice, and their blood pressure was measured one day before angiotensin II perfusion (tail cuff blood pressure measuring instrument BP-98A, Softron, Japan ), 10 mice with a body weight of about 25 g, blood pressure in the normal range, and similar systolic blood pressure were divided into cages and marked as 1-10. Nos. 1-5 were saline control group, and No. 6-10 were angiotensin II group.

[0045] 2. Activation of implantable micro-pumps (ALZET 1004 micro-osmotic pumps, DURECT, Cupertino, CA, USA): 48 hours before perfusion, a total of 10 implantable micro-pump bodies were taken out fro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method and application of a hypertensive retinopathy mouse animal model, and belongs to the technical field of biomedicine. According to the method, an implantable micro-pump filled with perfusate is subcutaneously embedded into a mouse, the perfusate is continuously pumped into the body of the mouse, the perfusate contains angiotensin II, the pumping dose of the angiotensin II is 2500-3500 ng/kg/min, and the pumping time is 3-4 weeks. A mouse is used as a model object, and an implanted trace pump is used for continuously pumping angiotensin II to improve systolic pressure of the mouse and increase retinal inflammation and thickness change so as to cause hypertensive retinopathy. The time for constructing the model is short and is only 3 weeks, the constructed mouse hypertensive retinopathy model has central retina thickening, blood vessel arteriovenous proportion change and morphological change, retina electrophysiological change, oxidative stress increase and inflammatory cytokine up-regulation, and basic pathological characteristics of human hypertensive retinopathy are simulated.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a preparation method and application of a mouse hypertensive fundus lesion model caused by continuous angiotensin II perfusion. Background technique [0002] Systemic hypertension is an important risk factor affecting the structure and function of the eye, and the increase of arterial blood pressure is the main reason for the pathophysiological changes and clinical symptoms of the retina of hypertension. Hypertensive retinopathy is present in 3% to 14% of adults over the age of 40. The main clinical manifestations of hypertensive retinopathy include retinal arterial thinning and reflection enhancement, arteriovenous ratio reduction, arteriovenous cross compression sign, patchy hemorrhages along the blood vessels, cotton wool spots, optic disc edema and arteriosclerosis in severe cases. a complication. Its pathophysiological basis is the decrease in the number of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01K67/02
CPCA01K67/02
Inventor 王帅纪力旸李靖李汇华
Owner THE SECOND HOSPITAL OF DALIAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap